Dupont Capital Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Dupont Capital Management’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,333	Closed	-$7K	–	1728
2022 Q3	$7K	Hold	8,333	–	–	﹤0.01%	1303
2022 Q2	$1K	Hold	8,333	–	–	﹤0.01%	1628
2022 Q1	$2K	Hold	8,333	–	–	﹤0.01%	1669
2021 Q4	$5K	Hold	8,333	–	–	﹤0.01%	1668
2021 Q3	$5K	Hold	8,333	–	–	﹤0.01%	1676
2021 Q2	$9K	Hold	8,333	–	–	﹤0.01%	1663
2021 Q1	$8K	Buy	+8,333	New	+$14.1K	﹤0.01%	1543

Dupont Capital Management's FLACW Position: Q4 2022 in Review

Dupont Capital Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 8,333 shares — an estimated $7K sold.

Dupont Capital Management first reported a position in FLACW in Q1 2021 and held it in 7 quarters. The position peaked at $9K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Dupont Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Dupont Capital Management sold 8,333 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $7K.
Dupont Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
Dupont Capital Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $9K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.